Currently, there are 388.84M common shares owned by the public and among those 366.95M shares have been available to trade.
The company’s stock has a 5-day price change of -0.37% and -2.25% over the past three months. VFC shares are trading -28.46% year to date (YTD), with the 12-month market performance down to -27.61% lower. It has a 12-month low price of $11.00 and touched a high of $21.17 over the same period. VFC has an average intraday trading volume of 8.21 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -1.30%, 3.02%, and -13.14% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of VF Corp. (NYSE: VFC) shares accounts for 90.16% of the company’s 388.84M shares outstanding.
It has a market capitalization of $5.23B and a beta (3y monthly) value of 1.54. The earnings-per-share (ttm) stands at -$2.49. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.08% over the week and 3.40% over the month.
Earnings per share for the fiscal year are expected to decrease by -2.13%, and 47.39% over the next financial year.
Looking at the support for the VFC, a number of firms have released research notes about the stock. Telsey Advisory Group stated their Market Perform rating for the stock in a research note on May 23, 2024, with the firm’s price target at $13. Telsey Advisory Group coverage for the VF Corp. (VFC) stock in a research note released on May 17, 2024 offered a Outperform rating with a price target of $18. Exane BNP Paribas was of a view on April 12, 2024 that the stock is Neutral, while Goldman gave the stock Neutral rating on February 07, 2024, issuing a price target of $19- $14. JP Morgan on their part issued Neutral rating on November 15, 2023.
